From the understanding of the mechanisms of inflammation in asthma to improve the formulation of inhaled drugs

Tadeusz Płusa

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Contact Instructions for authors

1/2010
vol. 13

Send email

Copy url:

abstract:

From the understanding of the mechanisms of inflammation in asthma to improve the formulation of inhaled drugs

Tadeusz Płusa

Przew Lek 2010; 1: 47-52

Online publish date: 2010/03/04

View full text Get citation

Structural and functional changes in small bronchi (< 2 mm in diameter) play an important role in reducing the air flow in bronchial asthma. New techniques using gas analysis and high-resolution computed tomography shows the direction for new applications. The new formulations of inhaled β2-agonists and glucocorticosteroids in aerosols with ultra-fine particles may be more effective in controlling asthma. New combinations are more effective than previously used, because they deposit in small bronchi.
Disclosed ciclesonide rapid therapeutic effect and its formulation indicate that it can be used in asthma exacerbation, and in severe and difficult asthma, where inflammation takes place in the peripheral bronchi.

keywords:

From the understanding of the mechanisms of inflammation in asthma to improve the formulation of inhaled drugs

Tadeusz Płusa

asthma, ultra-fine particles